## Abstract Zidovudine‐based antiretroviral therapies (ARTs) for treatment of HIV‐infected pregnant women have markedly reduced mother‐to‐child transmission of the human immunodeficiency virus (HIV‐1) from ∼25% to <1%. However, zidovudine (ZDV; AZT), a nucleoside analogue, induces chromosomal damag
Monitoring and evaluating the national program to prevent mother-to-child HIV transmission in Thailand
✍ Scribed by Siripon Kanshana; Thananda Naiwatanakul; R. J. Simonds; Pornsinee Amornwichet; Achara Teeraratkul; Mary Culnane; Nartlada Chantharojwong; Khanchit Limpakarnjanarat
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 75 KB
- Volume
- 2004
- Category
- Article
- ISSN
- 1097-6736
- DOI
- 10.1002/ev.126
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The present research was aimed to prevent mother‐to‐child transmission of HIV; to use RT‐PCR in order to detect, 6 months after birth, infected children; and to test the antiretroviral resistance of both children and mothers in order to offer them a suitable therapy. At the Saint Camill
## Abstract In the Western Cape province of South Africa, an intensified regimen for the prevention‐of‐mother‐to‐child‐transmission‐of‐HIV consisting of zidovudine (AZT) from 34 weeks of pregnancy plus single dose (sd) nevirapine (NVP) during labor was instituted in 2004. The newborn baby receives
## Abstract This paper argues that current HIV/AIDS intervention models in southern India—in particular, those targeting the prevention of parent‐to‐child transmission (PPTCT)—underutilize the private sector and thereby compromise an efficient integration of HIV/AIDS humanitarian responses into Ind